following hormone and metabolic modulators are prohibited: ... 3. Agents modifying …., but not limited, to: Myostatin inhibitors such as: Agents reducing or ablating myostatin expression; Myostatin-binding

der WADA Verbotsliste 2018: The following hormone and metabolic modulators are prohibited: ... 4. Agents modifying myostatin function(s) including, but not limited, to: myostatin inhibitors. ... Literatur

performance-enhancing agents in sports Myostatin Inhibitory Proteins - New Publication Foto: clipdealer.com / Myostatin Inhibitory Proteins are considered as performance-enhancing agents in sports first published [...] therefore not only promising therapeutics for muscular diseases but also potential performance-enhancing agents in sports. Within this study, protein precipitation and liquid chromatography high-resolution tandem

Grindeks (Riga, Lettland) zur Wirkung von Meldonium Mildronate® is the leading agent of the cardiovascular group antiischemic agent of a metabolic action: " Acts as antiischemic cell protector in patients with

University of Cologne. He is also Director of the European Monitoring Center for Emerging Doping Agents, a forensic chemist, Editor-in-Chief of Drug Testing & Analysis, and a PCC scientist. He discusses

Fresenius Zeitschrift für Analytische Chemie, 279 (1976) 129 131 DONIKE M: The detection of doping agents in blood. Br J Sports Med, 10 (1976) 147 154 DONIKE M: Abfallprodukte der Dopinganalytik. Ärztliche [...] Florenz, 1987. International Athletic Foundation, Florenz (1988) 53 80 DONIKE M: Detection of Dope Agents. Fresenius Zeitschrift für Analytische Chemie, 330 (1988) 337 DONIKE M, SCHANZER W: Mißbrauch von

B, Graf R, Clavien PA. Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial.BMC

M., Schänzer, W.: Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy

human urine and blood matrices. The obtained results allow extension of the test spectrum of doping agents in multitarget screening assays for growth hormone-releasing factors from human urine.

-gene- and IGF1 -gene-containing materials were analyzed for the presence of potential gene doping agents using a newly developed analytical approach, allowing for the detection of transgenic DNA corresponding